ANTIEPILEPTIC EFFECTS OF LAMIKTAL IN YOUN G-CHILDREN AND ADOLESCENTS

Antiepileptic effects of lamiktal (lamotrigine) produced in Great Brit ain (Wellcome) was tried in 7 children aged 3 - 14 and 3 adults aged 1 8 - 30. Of them 6 patients and 4 patients suffered from temporal polim orphic fits and general paroxysms, respectively. Upon 3-month follow-u p it was found that the fits discontinued in 4 patients, frequency of the paroxysms reduced or they became abortive in 6 cases. EEG changes were insignificant. No side effects occurred. Lamiktal is recommended in polymorphic seizures in children and adults, in failure of other an ticonvulsants in patients frequently affected with epileptic paroxysms .